There are no products in your shopping cart.
Dr. Ping's Story Links
A potent bone-building drug may cut the risk of relapse in premenopausal women with early breast cancer, a study shows.
In a study of more than 1,800 patients, women who got two injections a year of the bone drug Zometa were about one-third less likely to suffer a recurrence than those who did not.
"Zometa creates a tumor-hostile environment that helps to keep cancer away, and it is very safe," says researcher Michael Gnant, MD, professor of surgery at the Medical University of Vienna, Austria.
- Login or register to post comments
- report spam









Recent Comments
22 hours 1 min ago
3 weeks 10 hours ago
3 weeks 1 day ago
6 weeks 2 days ago
10 weeks 1 day ago
11 weeks 11 hours ago
14 weeks 6 days ago
15 weeks 6 days ago
17 weeks 6 days ago
19 weeks 1 day ago